Sign In
4 Nov 2008 13:10
ο»Ώ
4thΒ November 2008
REGEN THERAPEUTICS PLCΒ
("ReGen" or the "Company"; Ticker: (RGT))
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES
1.Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
ReGen Therapeutics Plc
Β
2.Reason for the notification:
An acquisition or disposal of voting rights
Β
3.Full name of person(s) subject to the notification obligation (iii):
Andrew Clement Wilson
Β
4.Full name of shareholder(s) (if difference from 3):
As Above
Β
5.Date of the transaction and date on which the threshold is crossed or reached (v):
3rdΒ November 2008
Β
6.Date on which issued notified:
4thΒ November 2008
Β
7.Threshold(s) that is/are crossed or reached:
13%
Β
8.Notified detailsΒ
A: Voting rights attached to shares
Class/type of share if possible using the ISIN Code GB00B28XMY25
Situation Previous to the triggering transaction (vi) -
Number of Shares 1,720,000
Number of Voting Rights (viii) 1,720,000
Resulting situation after the triggering transaction (viii) -
Number of Shares 1,870,750
Number of Voting Rights - Direct (x) 1,870,750
Number of Voting Rights - Indirect (xi) N/A
% of voting rights - Direct 13.45
% of voting rights - Indirect N/A
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of financial instrument N/A
Expiration date (xiii) N/A
Exercise/Conversion Period/Date (xiv) N/A
Number of voting rights that may be acquired if theΒ
instrument is exercised/converted N/A
% of voting rights N/A
Total (A+B)
Number of voting rights 1,870,750
% of voting rights 13.45
Β
9.Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):Β Giltspur Nominees Limited-Brewin Dolphin
Proxy Voting:
Β
10.Name of the proxy holder: N/A
Β
11.Number of voting rights proxy holder will cease to hold: N/A
Β
12.Date on which proxy holder will cease to hold voting rights: Β N/A
Β
13.Additional information: Brewin Dolphin act as
Β Broker to client
Β
14.Contact name: Patrick Wilson
Β
15.Contact telephone number: 028 90 446000
For further information:
For further information, please contact: Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396Β
Follow the stocks
